Moderna fourth-quarter revenue beats estimates

Investing.com -- Moderna Inc (NASDAQ: MRNA) has reported a steep drop in fourth-quarter revenue to $2.81 billion, but still topped average analyst expectations.

Shares in the U.S. drugmaker were higher in premarket trading on Thursday.

This is a developing story. Please check back later for updates.

You May Also Be Interested In

• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• Venezuela oil export revenue rises 21.5% in first quarter
• Short squeeze payback: Avis Budget gains 8% on massive $650M Pentwater settlement